Written question asked by Baroness Manzoor (Liberal Democrat) on Monday, 12 January 2015, in the House of Lords. It was due for an answer on Monday, 26 January 2015. It was answered by Earl Howe (Conservative) on Monday, 26 January 2015 on behalf of the Department of Health.
Antimicrobial Resistance
- Question
-
To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 31 December (HL3763) concerning antimicrobial resistance, how they will consult industry and recruit the group investigating interim issues; and how they will investigate pricing and reimbursement arrangements before the conclusion of the O'Neil review.
- Answer
-
The group to explore how to address interim issues pending the independent Review on Antimicrobial Resistance’s conclusion has not yet been established. Departmental officials have been working with relevant industry trade bodies, which will nominate industry participants in the group. Any discussion of the pricing and reimbursement of newly launched antibiotics or soon-to-be launched antibiotics will need to be framed in a way which does not pre-empt the conclusions of the Review, which is now underway.
Secondary information
- Type
- Written question
- Reference
- HL4100
- Session
- 2014-15
- Related items
- Subjects
- Antimicrobial resistance
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-09-21 10:50:02 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2014-15/HL4100
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2014-15/HL4100
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2014-15/HL4100